The fund will provide capital for MIT-founded Gingko's own spinouts and has attracted LPs including Viking Global Investors, General Atlantic and Cascade Investment.

Ginkgo Bioworks, a US-based microbe engineering spinout of Massachusetts Institute of Technology, unveiled a $350m investment vehicle called Ferment Consortium yesterday that will finance its spinouts.
Ferment Consortium is funded by Gingko’s “major investors,” the company said, identifying hedge fund manager Viking Global Investors, growth equity firm General Atlantic and investment holding company Cascade Investment as backers.
Founded in 2009, Ginkgo has built a biotechnology platform to grow organisms with industrial applications, spanning areas such as consumer goods, nutrition,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in